Gibson Dunn & Crutcher advised Merck on the transaction and Wilson Sonsini Goodrich & Rosati advised LaNova Medicines. Merck (NYSE: MRK), known as MSD outside of...
You must be a Standard 1 Year member to access this content.
King & Spalding secured final summary judgments for Merck and Organon in the first two cases to be prepared for trial in a major nationwide pharmaceutical...
You must be a Standard 1 Year member to access this content.
Hogan Lovells acted as Merck’s legal advisor in this transaction. Centerview Partners LLC acted as financial advisor to Curon and Goodwin Procter LLP as the company’s...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
You must be a Standard 1 Year member to access this content.
Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
You must be a Standard 1 Year member to access this content.
Fried Frank acted as counsel to Merck & Co., while Davis Polk advised the representatives of the underwriters on the offering. Merck & Co., Inc. issued...
You must be a Standard 1 Year member to access this content.
